首页> 外文期刊>ACS Omega >Development and Validation of a New High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Coenzyme Q10, Phosphatidylserine, and Vitamin C from a Cutting-Edge Liposomal Vehiculization
【24h】

Development and Validation of a New High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Coenzyme Q10, Phosphatidylserine, and Vitamin C from a Cutting-Edge Liposomal Vehiculization

机译:新型高效液相色谱方法的开发和验证,该方法可同时从尖端脂质体脂质化中定量定量辅酶Q10,磷脂酰丝氨酸和维生素C

获取原文
获取外文期刊封面目录资料

摘要

A high-performance liquid chromatography (HPLC) method was developed to simultaneously quantify three widely used active substances such as coenzyme Q10, phosphatidylserine, and vitamin C. This new method optimizes current timing and costs in the analyses of these three active substances. Additionally, since the analyzed compounds were encapsulated on a cutting-edge liposomal formulation, further processing was necessary to be developed prior to HPLC analyses. The technique was studied and adequately validated in accordance with the guidelines of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) regarding selectivity, linearity, accuracy, precision, and robustness. After data treatment of results, linear regressions for all active substances showed an optimal linearity with a correlation coefficient of >0.999 in the concentration range between 70 to 130% of the liposomal formulation and less than a 3% relative standard deviation (RSD) in accuracy and precision.
机译:开发了一种高效液相色谱(HPLC)方法,以同时量化三种广泛使用的活性物质,例如辅酶Q10,磷脂酰丝氨酸和维生素C。这种新方法优化了这三种活性物质的分析的当前时间和成本。另外,由于分析的化合物被封装在最先进的脂质体制剂上,因此在进行HPLC分析之前有必要进行进一步的处理。根据国际人用药品技术要求协调委员会(ICH)关于选择性,线性,准确性,精密度和鲁棒性的指南,对该技术进行了研究和充分验证。在对结果进行数据处理后,所有活性物质的线性回归均显示出最佳线性,在脂质体制剂的70%至130%的浓度范围内,相关系数> 0.999,准确度小于3%的相对标准偏差(RSD)和精度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号